Skip to main content
Erschienen in: The Cerebellum 3/2019

01.06.2019 | Original Paper

Fall Risk in Relation to Individual Physical Activity Exposure in Patients with Different Neurodegenerative Diseases: a Pilot Study

verfasst von: Karin Srulijes, Jochen Klenk, Michael Schwenk, Cornelia Schatton, Lars Schwickert, Kristin Teubner-Liepert, Miriam Meyer, Srijana K.C., Walter Maetzler, Clemens Becker, Matthis Synofzik

Erschienen in: The Cerebellum | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Falls in patients with neurodegenerative diseases (NDDs) have enormous detrimental consequences. A better understanding of the interplay between physical activity (PA) and fall risk might help to reduce fall frequency. We aimed to investigate the association between sensor-based PA and fall risk in NDDs, using “falls per individual PA exposure time” as a novel measure. Eighty-eight subjects (n = 31 degenerative ataxia (DA), n = 14 Parkinson’s disease (PD), n = 12 progressive supranuclear palsy (PSP) and 31 healthy controls) were included in this pilot study. PA was recorded in free-living environments with three-axial accelerometers (activPAL™) over 7 days. Falls were prospectively assessed over 12 months. Fall incidence was calculated by (i) absolute number of falls per person years (py) and (ii) falls per exposure to individual PA. Absolute fall incidence was high in all three NDDs, with differing levels (DA, 9 falls/py; PD, 14 falls/py; PSP, 29 falls/py). Providing a more fine-grained view on fall risk, correction for individual exposure to PA revealed that measures of low walking PA were associated with higher fall incidence in all three NDDs. Additionally, higher fall incidence was associated with more sit-to-stand transfers in PD and longer walking bouts in PSP. Our results suggest that low walking PA is a risk factor for falls in DA, PD and PSP, indicating the potential benefit of increasing individual PA in these NDDs to reduce fall risk. Moreover, they show that correction for individual exposure to PA yields a more differentiated view on fall risk within and across NDDs.
Literatur
1.
Zurück zum Zitat Bryant MS, Rintala DH, Hou JG, Protas EJ. Relationship of falls and fear of falling to activity limitations and physical inactivity in Parkinson’s disease. J Aging Phys Act. 2015;23(2):187–93.CrossRefPubMed Bryant MS, Rintala DH, Hou JG, Protas EJ. Relationship of falls and fear of falling to activity limitations and physical inactivity in Parkinson’s disease. J Aging Phys Act. 2015;23(2):187–93.CrossRefPubMed
2.
Zurück zum Zitat Mactier K, Lord S, Godfrey A, Burn D, Rochester L. The relationship between real world ambulatory activity and falls in incident Parkinson’s disease: influence of classification scheme. Parkinsonism Relat Disord. 2015;21(3):236–42.CrossRefPubMed Mactier K, Lord S, Godfrey A, Burn D, Rochester L. The relationship between real world ambulatory activity and falls in incident Parkinson’s disease: influence of classification scheme. Parkinsonism Relat Disord. 2015;21(3):236–42.CrossRefPubMed
3.
Zurück zum Zitat Lewis ZH, Markides KS, Ottenbacher K, Al Snih S. The role of physical activity and physical function on the risk of falls in older Mexican Americans. J Aging Phys Act. 2015. Lewis ZH, Markides KS, Ottenbacher K, Al Snih S. The role of physical activity and physical function on the risk of falls in older Mexican Americans. J Aging Phys Act. 2015.
4.
Zurück zum Zitat Butler AA, Lord SR, Taylor JL, Fitzpatrick RC. Ability versus hazard: risk-taking and falls in older people. J Gerontol A Biol Sci Med Sci. 2015;70(5):628–34.CrossRefPubMed Butler AA, Lord SR, Taylor JL, Fitzpatrick RC. Ability versus hazard: risk-taking and falls in older people. J Gerontol A Biol Sci Med Sci. 2015;70(5):628–34.CrossRefPubMed
5.
Zurück zum Zitat Allen NE, Schwarzel AK, Canning CG. Recurrent falls in Parkinson’s disease: a systematic review. Parkinsons Dis. 2013;2013:906274.PubMedPubMedCentral Allen NE, Schwarzel AK, Canning CG. Recurrent falls in Parkinson’s disease: a systematic review. Parkinsons Dis. 2013;2013:906274.PubMedPubMedCentral
6.
Zurück zum Zitat Fonteyn EM, Schmitz-Hubsch T, Verstappen CC, Baliko L, Bloem BR, Boesch S, et al. Prospective analysis of falls in dominant ataxias. Eur Neurol. 2013;69(1):53–7.CrossRefPubMed Fonteyn EM, Schmitz-Hubsch T, Verstappen CC, Baliko L, Bloem BR, Boesch S, et al. Prospective analysis of falls in dominant ataxias. Eur Neurol. 2013;69(1):53–7.CrossRefPubMed
7.
Zurück zum Zitat Williams DR, Watt HC, Lees AJ. Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry. 2006;77(4):468–73.CrossRefPubMedPubMedCentral Williams DR, Watt HC, Lees AJ. Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry. 2006;77(4):468–73.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47(1):1–9.CrossRefPubMed Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47(1):1–9.CrossRefPubMed
9.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–4.CrossRefPubMedPubMedCentral Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181–4.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, et al. Development and validation of the unified multiple system atrophy rating scale (UMSARS). Mov Disord. 2004;19(12):1391–402.CrossRefPubMed Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, et al. Development and validation of the unified multiple system atrophy rating scale (UMSARS). Mov Disord. 2004;19(12):1391–402.CrossRefPubMed
11.
Zurück zum Zitat Shumway-Cook A. Theory and practical applications. Mot Control. 1995. Shumway-Cook A. Theory and practical applications. Mot Control. 1995.
12.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRefPubMed Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRefPubMed
13.
Zurück zum Zitat Drane DL, Yuspeh RL, Huthwaite JS, Klingler LK. Demographic characteristics and normative observations for derived-trail making test indices. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15(1):39–43.PubMed Drane DL, Yuspeh RL, Huthwaite JS, Klingler LK. Demographic characteristics and normative observations for derived-trail making test indices. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15(1):39–43.PubMed
14.
Zurück zum Zitat Hautzinger M, Bailer M. Allgemeine Depressions Skala. Manual. Göttingen: Beltz; 1993. Hautzinger M, Bailer M. Allgemeine Depressions Skala. Manual. Göttingen: Beltz; 1993.
15.
Zurück zum Zitat Kempen GI, Yardley L, van Haastregt JC, Zijlstra GA, Beyer N, Hauer K, et al. The Short FES-I: a shortened version of the falls efficacy scale-international to assess fear of falling. Age Ageing. 2008;37(1):45–50.CrossRefPubMed Kempen GI, Yardley L, van Haastregt JC, Zijlstra GA, Beyer N, Hauer K, et al. The Short FES-I: a shortened version of the falls efficacy scale-international to assess fear of falling. Age Ageing. 2008;37(1):45–50.CrossRefPubMed
16.
Zurück zum Zitat Ryan CG, Grant PM, Tigbe WW, Granat MH. The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med. 2006;40(9):779–84.CrossRefPubMedPubMedCentral Ryan CG, Grant PM, Tigbe WW, Granat MH. The validity and reliability of a novel activity monitor as a measure of walking. Br J Sports Med. 2006;40(9):779–84.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Grant PM, Ryan CG, Tigbe WW, Granat MH. The validation of a novel activity monitor in the measurement of posture and motion during everyday activities. Br J Sports Med. 2006;40(12):992–7.CrossRefPubMedPubMedCentral Grant PM, Ryan CG, Tigbe WW, Granat MH. The validation of a novel activity monitor in the measurement of posture and motion during everyday activities. Br J Sports Med. 2006;40(12):992–7.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Lamb SE, Jorstad-Stein EC, Hauer K, Becker C, Prevention of Falls Network E, Outcomes Consensus G. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc. 2005;53(9):1618–22.CrossRefPubMed Lamb SE, Jorstad-Stein EC, Hauer K, Becker C, Prevention of Falls Network E, Outcomes Consensus G. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc. 2005;53(9):1618–22.CrossRefPubMed
19.
Zurück zum Zitat Klenk J, Kerse N, Rapp K, Nikolaus T, Becker C, Rothenbacher D, et al. Physical activity and different concepts of fall risk estimation in older people—results of the ActiFE-Ulm study. PLoS One. 2015;10(6):e0129098.CrossRefPubMedPubMedCentral Klenk J, Kerse N, Rapp K, Nikolaus T, Becker C, Rothenbacher D, et al. Physical activity and different concepts of fall risk estimation in older people—results of the ActiFE-Ulm study. PLoS One. 2015;10(6):e0129098.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Klockgether T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol. 2010;9(1):94–104.CrossRefPubMed Klockgether T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol. 2010;9(1):94–104.CrossRefPubMed
21.
Zurück zum Zitat Respondek G, Hoglinger GU. The phenotypic spectrum of progressive supranuclear palsy. Parkinsonism Relat Disord. 2016;22(Suppl 1):S34–6.CrossRefPubMed Respondek G, Hoglinger GU. The phenotypic spectrum of progressive supranuclear palsy. Parkinsonism Relat Disord. 2016;22(Suppl 1):S34–6.CrossRefPubMed
22.
Zurück zum Zitat Fonteyn EM, Schmitz-Hubsch T, Verstappen CC, Baliko L, Bloem BR, Boesch S, et al. Falls in spinocerebellar ataxias: results of the EuroSCA Fall study. Cerebellum. 2010;9(2):232–9.CrossRefPubMed Fonteyn EM, Schmitz-Hubsch T, Verstappen CC, Baliko L, Bloem BR, Boesch S, et al. Falls in spinocerebellar ataxias: results of the EuroSCA Fall study. Cerebellum. 2010;9(2):232–9.CrossRefPubMed
23.
Zurück zum Zitat Weiss A, Herman T, Giladi N, Hausdorff JM. Objective assessment of fall risk in Parkinson’s disease using a body-fixed sensor worn for 3 days. PLoS One. 2014;9(5):e96675.CrossRefPubMedPubMedCentral Weiss A, Herman T, Giladi N, Hausdorff JM. Objective assessment of fall risk in Parkinson’s disease using a body-fixed sensor worn for 3 days. PLoS One. 2014;9(5):e96675.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, et al. A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord. 2007;22(13):1892–900.CrossRefPubMed Pickering RM, Grimbergen YA, Rigney U, Ashburn A, Mazibrada G, Wood B, et al. A meta-analysis of six prospective studies of falling in Parkinson’s disease. Mov Disord. 2007;22(13):1892–900.CrossRefPubMed
25.
Zurück zum Zitat Zieschang T, Schwenk M, Becker C, Uhlmann L, Oster P, Hauer K. Falls and physical activity in persons with mild to moderate dementia participating in an intensive motor training: randomized controlled trial. Alzheimer Dis Assoc Disord. 2017;31:307–14.CrossRefPubMed Zieschang T, Schwenk M, Becker C, Uhlmann L, Oster P, Hauer K. Falls and physical activity in persons with mild to moderate dementia participating in an intensive motor training: randomized controlled trial. Alzheimer Dis Assoc Disord. 2017;31:307–14.CrossRefPubMed
26.
Zurück zum Zitat Ramsey VK, Miszko TA, Horvat M. Muscle activation and force production in Parkinson’s patients during sit to stand transfers. Clin Biomech. 2004;19(4):377–84.CrossRef Ramsey VK, Miszko TA, Horvat M. Muscle activation and force production in Parkinson’s patients during sit to stand transfers. Clin Biomech. 2004;19(4):377–84.CrossRef
Metadaten
Titel
Fall Risk in Relation to Individual Physical Activity Exposure in Patients with Different Neurodegenerative Diseases: a Pilot Study
verfasst von
Karin Srulijes
Jochen Klenk
Michael Schwenk
Cornelia Schatton
Lars Schwickert
Kristin Teubner-Liepert
Miriam Meyer
Srijana K.C.
Walter Maetzler
Clemens Becker
Matthis Synofzik
Publikationsdatum
01.06.2019
Verlag
Springer US
Erschienen in
The Cerebellum / Ausgabe 3/2019
Print ISSN: 1473-4222
Elektronische ISSN: 1473-4230
DOI
https://doi.org/10.1007/s12311-018-1002-x

Weitere Artikel der Ausgabe 3/2019

The Cerebellum 3/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.